Nandini Piramal, Piramal Pharma Chairperson says the company is working to reduce its reliance on China for raw materials while conveying that India can be a reliable partner for the US pharmaceutical industry. She spoke to Haslinda Amin on the sidelines of Bloomberg New Economy Forum in New Delhi. (Source: Bloomberg)
Nandini Piramal, Piramal Pharma Chairperson says the company is working to reduce its reliance on China for raw materials while conveying that India can be a reliable partner for the US pharmaceutical industry. She spoke to Haslinda Amin on the sidelines of Bloomberg New Economy Forum in New Delhi. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/c82ef1975c0221cd6af4e27b3735af7e6d5a457d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Piramal Pharma On Cutting Exposure To China"></iframe>